Search Within

GME, Medicine

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (21)
  2. Journal Article (18)
  3. Editorial (2)
  4. Research Letter (2)
  5. Review (2)
  6. Correspondence (1)
Groups
  1. Advanced Practice Providers (46)
  2. Graduate Medical Education (46)
  3. Department of Medicine (44)
  4. Hematology-Oncology Fellows (31)
  5. Hematologic Malignancies, Division of (29)
  6. Center for Hematologic Malignancies (28)

More Groups

People
  1. Andrew Zelenetz (12)
  2. Ahmet Dogan (11)
  3. Maria Palomba (9)
  4. Meghan Thompson (9)
  5. Anita Kumar (8)
  6. Ariela Noy (8)

More People

Years
  1. 2025 (2)
  2. 2024 (10)
  3. 2023 (12)
  4. 2022 (9)
  5. 2021 (11)
  6. 2020 (2)
Publications
  1. Blood (13)
  2. Journal of Clinical Oncology (7)
  3. Clinical Cancer Research (3)
  4. American Journal of Hematology (1)
  5. Annals of Oncology (1)
  6. Applied Clinical Informatics (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. American Society of Clinical Oncology (9)
  3. Oxford University Press (4)
  4. American Association for Cancer Research (3)
  5. Nature Publishing Group (3)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Nasopharynx cancer in the United States: Racial and ethnic disparities in stage at presentation
    Journal Article

    Dee, E. C.; Wang, S.; Ho, F. D. V.; Patel, R. R.; Lapen, K.; Wu, Y.; Yang, F.; Patel, T. A.; Feliciano, E. J. G.; McBride, S. M.; more...
    Laryngoscope (2025)

    Fulltext@MSK | Save
  • Manufacture of anti-BCMA CAR T cell is feasible after salvage autologous or allogeneic hematopoietic stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Perica, K.; Nagel, K.; Payson, E.; Hosszu, K. K.; Chung, D. J.; Landau, H. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Final response and survival results from a phase II trial of pembrolizumab and entinostat in relapsed/refractory Hodgkin lymphoma
    Meeting Abstract

    Stuver, R.; Vardhana, S. A.; Ganesan, N.; Boardman, A. P.; Caron, P.; Chang, T.; David, K. A.; Epstein-Peterson, Z. D.; Falchi, L.; Ghione, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Waiting to exhale: The feasibility and appropriateness of home blood oxygen monitoring in oncology patients post–hospital discharge
    Journal Article

    Liu, S. Y.; Doshi, S. D.; Ebstein, A. M.; Holland, J.; Sapir, A.; Leung, M.; Huang, J.; Fahy, R.; Salvaggio, R.; Begue, A.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Oral minoxidil for late alopecia in cancer survivors
    Journal Article

    Kuo, A. M. S.; Reingold, R. E.; Ketosugbo, K. F.; Pan, A.; Kraehenbuehl, L.; Dusza, S.; Gajria, D.; Lake, D. E.; Bromberg, J. F.; Traina, T. A.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • Expect the unexpected: Fulminant myocardial cytotoxic injury from Trabectedin
    Journal Article

    Tsay, A. J.; Satish, M.; Corley, E.; Ezema, A.; DeJesus, N.; Wisely, S.; McAleer, E.; Zhang, C.; Yuan, S.; Homan, E.; more...
    Cardio-Oncology (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma
    Meeting Abstract

    Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Transforming patient-centered cancer care using telehealth: The MATCHES center
    Review

    Bange, E. M.; Daly, R. M.; Lipitz-Snyderman, A.; Kuperman, G.; Polubriaginof, F. C. G.; Liebertz, C.; Doshi, S. D.; Stevanovic, K.; Chan, K.; Bernal, C.; more...
    Journal of the National Cancer Institute - Monographs (2024)

    Fulltext@MSK | Save